A collaborative study entitled “Addressing the Biochemical Foundations of a Glucose-Based “Trojan Horse”-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment” with the Filip Ekholm’s research group was recently published in Molecular Pharmaceutics. The study revealed novel carboranyl-glucose conjugates to be potential molecules to be used as boron carriers in BNCT of malignant...
